Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Lymphocytic Leukemia
>>
JAK
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Jakafi
(ruxolitinib) / Incyte
AT9283
/ Otsuka
Vonjo
(pacritinib) / SOBI
itacitinib
(INCB039110) / Incyte
lestaurtinib
(CEP-701) / Teva, Kyowa Kirin
Olumiant
(baricitinib) / Eli Lilly
Rozlytrek
(entrectinib) / Roche
